288 related articles for article (PubMed ID: 25740465)
1. Vascular repair utilising immobilised heparin conjugate for protection against early activation of inflammation and coagulation.
Nordling S; Hong J; Fromell K; Edin F; Brännström J; Larsson R; Nilsson B; Magnusson PU
Thromb Haemost; 2015 Jun; 113(6):1312-22. PubMed ID: 25740465
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine-1-phosphate improves endothelialization with reduction of thrombosis in recellularized human umbilical vein graft by inhibiting syndecan-1 shedding in vitro.
Hsia K; Yang MJ; Chen WM; Yao CL; Lin CH; Loong CC; Huang YL; Lin YT; Lander AD; Lee H; Lu JH
Acta Biomater; 2017 Mar; 51():341-350. PubMed ID: 28110073
[TBL] [Abstract][Full Text] [Related]
3. Myxoma viral serpin, Serp-1, a unique interceptor of coagulation and innate immune pathways.
Viswanathan K; Liu L; Vaziri S; Dai E; Richardson J; Togonu-Bickersteth B; Vatsya P; Christov A; Lucas AR
Thromb Haemost; 2006 Mar; 95(3):499-510. PubMed ID: 16525579
[TBL] [Abstract][Full Text] [Related]
4. Tailoring of the dopamine coated surface with VEGF loaded heparin/poly-L-lysine particles for anticoagulation and accelerate in situ endothelialization.
Liu Y; Zhang J; Wang J; Wang Y; Zeng Z; Liu T; Chen J; Huang N
J Biomed Mater Res A; 2015 Jun; 103(6):2024-34. PubMed ID: 25256819
[TBL] [Abstract][Full Text] [Related]
5. Biofunctionalization of titanium surface with multilayer films modified by heparin-VEGF-fibronectin complex to improve endothelial cell proliferation and blood compatibility.
Wang HG; Yin TY; Ge SP; Zhang Q; Dong QL; Lei DX; Sun DM; Wang GX
J Biomed Mater Res A; 2013 Feb; 101(2):413-20. PubMed ID: 22865832
[TBL] [Abstract][Full Text] [Related]
6. The effect of anticoagulants and the role of thrombin on neutrophil-endothelial cell interactions in septic shock.
Tsen A; Kirschenbaum LA; LaRow C; Khan R; Kurtz S; Bansal S; Astiz ME
Shock; 2009 Feb; 31(2):120-4. PubMed ID: 18636042
[TBL] [Abstract][Full Text] [Related]
7. Low-thrombogenic fibrin-heparin coating promotes in vitro endothelialization.
Kaplan O; Hierlemann T; Krajewski S; Kurz J; Nevoralová M; Houska M; Riedel T; Riedelová Z; Zárubová J; Wendel HP; Brynda E
J Biomed Mater Res A; 2017 Nov; 105(11):2995-3005. PubMed ID: 28646555
[TBL] [Abstract][Full Text] [Related]
8. Immobilization of heparin/poly-(L)-lysine nanoparticles on dopamine-coated surface to create a heparin density gradient for selective direction of platelet and vascular cells behavior.
Liu T; Liu Y; Chen Y; Liu S; Maitz MF; Wang X; Zhang K; Wang J; Wang Y; Chen J; Huang N
Acta Biomater; 2014 May; 10(5):1940-54. PubMed ID: 24342042
[TBL] [Abstract][Full Text] [Related]
9. Interaction of C1 inhibitor with thrombin on the endothelial surface.
Caccia S; Castelli R; Maiocchi D; Bergamaschini L; Cugno M
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):571-5. PubMed ID: 21959589
[TBL] [Abstract][Full Text] [Related]
10. [The role of heparin in current therapy of thrombotic disease].
Komarnicki M
Pol Arch Med Wewn; 1982 Apr; 67(4):183-7. PubMed ID: 6752906
[No Abstract] [Full Text] [Related]
11. Surface modification of pig endothelial cells with a branched heparin conjugate improves their compatibility with human blood.
Bongoni AK; Salvaris E; Nordling S; Klymiuk N; Wolf E; Ayares DL; Rieben R; Magnusson PU; Cowan PJ
Sci Rep; 2017 Jun; 7(1):4450. PubMed ID: 28667310
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis.
Iba T; Levy JH
J Thromb Haemost; 2018 Feb; 16(2):231-241. PubMed ID: 29193703
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-4-dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin.
Kaneider NC; Förster E; Mosheimer B; Sturn DH; Wiedermann CJ
Thromb Haemost; 2003 Dec; 90(6):1150-7. PubMed ID: 14652650
[TBL] [Abstract][Full Text] [Related]
14. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
[TBL] [Abstract][Full Text] [Related]
15. Locally available heparin modulates inflammatory cell recruitment in a manner independent of anticoagulant activity.
Lever R; Smailbegovic A; Page CP
Eur J Pharmacol; 2010 Mar; 630(1-3):137-44. PubMed ID: 20043903
[TBL] [Abstract][Full Text] [Related]
16. Mast cell-derived heparin proteoglycans as a model for a local antithrombotic.
Lassila R; Jouppila A
Semin Thromb Hemost; 2014 Nov; 40(8):837-44. PubMed ID: 25393636
[TBL] [Abstract][Full Text] [Related]
17. Effect of DNase I treatment and neutrophil depletion on acute limb ischemia-reperfusion injury in mice.
Albadawi H; Oklu R; Raacke Malley RE; O'Keefe RM; Uong TP; Cormier NR; Watkins MT
J Vasc Surg; 2016 Aug; 64(2):484-493. PubMed ID: 26704988
[TBL] [Abstract][Full Text] [Related]
18. [Thrombogenic properties of the vessel and their inhibition].
Cazenave JP; Klein-Soyer C; Beretz A
Nouv Rev Fr Hematol (1978); 1982; 24(3):167-71. PubMed ID: 6752880
[TBL] [Abstract][Full Text] [Related]
19. Effects of surface-bound and intravenously administered heparin on cell-surface interactions: inflammation and coagulation.
Johnson G; Curry B; Cahalan L; Prater R; Biggerstaff J; Hussain A; Gartner M; Cahalan P
Perfusion; 2013 May; 28(3):263-71. PubMed ID: 23401339
[TBL] [Abstract][Full Text] [Related]
20. N-desulfated non-anticoagulant heparin inhibits leukocyte adhesion and transmigration in vitro and attenuates acute peritonitis and ischemia and reperfusion injury in vivo.
Wan JG; Mu JS; Zhu HS; Geng JG
Inflamm Res; 2002 Sep; 51(9):435-43. PubMed ID: 12365716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
